Elevated risk of Parkinson's disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds a new study led by UCL researchers.
Oct 27, 2020
0
55
Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer, according ...
Sep 16, 2011
0
0
(HealthDay)—For patients with type 2 diabetes, exenatide twice daily added to insulin glargine is efficacious across body mass index (BMI) ranges, according to a study published online March 29 in Diabetes, Obesity and ...
Apr 11, 2016
0
0
A drug commonly used to treat diabetes may have disease-modifying potential to treat Parkinson's disease, a new UCL-led study suggests, paving the way for further research to define its efficacy and safety.
Aug 3, 2017
0
91
A drug made from the saliva of the Gila monster lizard is effective in reducing the craving for food. Researchers at the Sahlgrenska Academy, University of Gothenburg, have tested the drug on rats, who after treatment ceased ...
May 15, 2012
1
0
Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the ...
May 20, 2013
0
0
A type 2 diabetes treatment has been found to also have 'off-label' benefits for glucose control in the liver and in fatty cells known as adipose.1 Presented at The International Liver Congress 2016 in Barcelona, Spain, today, ...
Apr 15, 2016
0
5
(Medical Xpress)—Medications used to treat hypertension, diabetes and skin conditions could be doubling as treatments for Alzheimer's within 10 years according to researchers. A groundbreaking new study funded by Alzheimer's ...
Nov 1, 2012
0
0
Exenatide, a drug commonly prescribed to help patients with type 2 diabetes improve blood sugar control, also has a powerful and rapid anti-inflammatory effect, a University at Buffalo study has shown.
Nov 2, 2011
0
0
A direct, head-to-head comparison of two of the newer treatments available for type 2 diabetes yielded mixed results.
Nov 6, 2012
0
0
